Af­ter lead­ing Cel­gene buy­out, Matthew Ro­den leaves Bris­tol My­ers Squibb for ven­ture cap­i­tal firm

The past four years at Bris­tol My­ers Squibb have been busy for Matthew Ro­den. The se­nior VP and head of en­ter­prise strat­e­gy was be­hind the com­pa­ny’s ini­tial plan fol­low­ing its ma­jor $74 bil­lion Cel­gene buy­out last year. But now, it’s on to green­er pas­tures.

Ro­den’s been tapped as ex­ec­u­tive part­ner at Cam­bridge, MA-based ven­ture cap­i­tal firm MPM Cap­i­tal —  a move he said has al­ways been part of his long-term goals.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER